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Inﬂammationa b s t r a c t
Galactofuranoside derivatives were synthesised by the classic Fischer glycosydation method, and their
immune modulation properties were studied in vitro and in vivo. NMR spectroscopic and ESI-MS analyses
conﬁrmed the purity and authenticity of all derivatives. Their phagocyte capacities were tested in resi-
dent macrophages. Methyl b-galactofuranoside (GFB-Me) and n-octyl b-galactofuranoside (GFB-O) had
an immune stimulant effect at 25 lmol ml1 with an enhancement of 35.12% ± 0.06 SD and
17.49% ± 0.11 SD, respectively, but Methyl a-galactofuranoside (GFA-Me) and n-octyl a-galactofurano-
side (GFA-O) gave a low immune response. Methyl a-galactofuranoside 5,6-O-isopropylidene (GFA-IP)
and Methyl b-galactofuranoside 5,6-O-isopropylidene (GFB-IP) had negative values relative to the control
group of minus 4.96% ± 0.10 SD and 40.72% ± 0.07 SD, respectively. Furthermore, GFB-Me and GFB-Me-
IP were evaluated in vivo on the lethality induced by cecal ligation and puncture. Cytokine levels and
iNOS expression were determined and correlated to mortality data. The results showed that the free
HO-5 and HO-6 and the b-conﬁguration are essential for the induction of phagocytic activity by the galac-
tofuranosyl units. The methyl b-galactofuranosides also enhanced lethality during sepsis, increasing the
levels of pro-inﬂammatory cytokines and iNOS expression.
 2013 Elsevier Ireland Ltd. All rights reserved.1. Introduction
Carbohydrates are distributed on the external cell membranes
of all organisms and are involved in many functions related to spe-
ciﬁc interactions with the extracellular environment. They are
essential for the organisms, contributing to structural architecture,
cell integrity, growth, and speciﬁc cell surface phenomena, such as
differentiation, bio-signaling and recognition and interaction with
endogenous or exogenous substances [1]. The diversity of glyco-
conjugates and their organization on membranes or cell walls con-
fer important properties to pathogenic microorganisms, such as
their response to the environment, which gives rise to essential
tools that enhance their virulence; proliferation; and dissemina-
tion inside the host [2]. These properties have been shown in many
pathogenic fungi, bacteria, and protozoa. Curiously, Galactofura-nose-containing structures, many of which are pathogenic to
mammals, have been observed on these organisms, even though
they do not normally code for these carbohydrates. Several studies
showed that b-Galf epitopes are essential for virulence in several
pathogenic organisms [3]. Furthermore, b-Galf epitopes, such as
lipopeptidophosphoglycan (LPPG), glycoinositolphospholipids
(GIPLs), mucins from Trypanosoma cruzi, and lipophosphonoglycan
(LPG) from Leishmania spp. [3] have been assigned important roles
in the pathogenesis of protozoa. Many varieties of fungal cell sur-
face glycoconjugates containing these Galf epitopes have been
shown to be highly antigenic [3–5].
A few years ago, a human intelectin (hIntL) that binds to galac-
tofuranose residues was identiﬁed [6]. It was a glycoprotein con-
sisting of 295 amino acids with N-linked oligosaccharides. It had
the ability to activate the innate immune response in the presence
of Galf residues, which are recognized by animal lectins that func-
tion as phagocytosis receptors [6]. The afﬁnity of hIntL to the galac-
tofuranosyl epitopes of some bacterial carbohydrate chains
reinforces its function as a phagocytosis receptor, because in most
cases, galactofuranosyl residues are components of pathogens and
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speciﬁc lectin for recognizing galactofuranosyl units. In addition,
immunomodulator properties have been reported for many glyco-
conjugates and polysaccharides that contain Galf; therefore, these
polysaccharides are able to activate the innate immune system
in vitro and in vivo [3,4].
Since many pathogenic microorganisms have conserved Galf
glycan epitopes, here we investigate several galactofuranoside
derivatives for their in vitro immunomodulation in peritoneal mac-
rophages and in vivo activity of polymicrobial sepsis.2. Materials and methods
2.1. Preparation of galactofuranosides
The chemical strategies were based on: (a) the inﬂuence of the
anomeric conﬁguration, (b) the size of the aglycone substituent,
and (c) selective blocking of the HO-5, 6 groups of the Galf deriva-
tives (Fig. 1).
Galactose (500 mg) and Me-b-Galp were obtained from Sigma–
Aldrich, MO, USA. Commercial galactosewas stirred in amethanolic
solution (MeOH–H2SO4, 99.5:0.5 v/v, 100 mL) at 25 C for 16 h until
complete dissolution [7]. The solution was neutralised with aq.
NH4OH and ﬁltered to remove precipitated (NH4)2SO4. Ammonium
methyl sulphate was removed with Amberlite IR-400 (OH). The
two anomers were separated by chromatography on a column
(30  2.0 cm diameter) packed with 60G silica gel (Merck), the elu-
ents being progressive mixtures of CHCl3–MeOH, which gave pure
methyl b- and a-galactofuranosides (GFB-Me and GFA-Me, respec-
tively).n-Octyl galactofuranosides were prepared from the Me/Galf
mixture (100 mg), which was dissolved in MeOH, and n-octanol
was then added to give a ﬁnal solution (10 mL) containing octa-
nol-MeOH–H2SO4 (100:10:0.5, v/v/v). This solutionwasmaintained
for 48 h at 25 C, then neutralised and treated with an anionic resin,
as described above. Fractionationwas performed using the previous
protocol, and n-octyl b- and a-galactofuranosides (GFB-O and GFA-
O, respectively) were eluted with CHCl3-2-PrOH.
5,6-O-isopropylidene galactofuranosides were obtained by the
addition of a mixture of 2 mL acetone containing 0.1% H2SO4 to a
4 mL glass vial, where the mixtures were maintained for 4 h at
room temperature. The solutions were then neutralised with
160 lL aqueous 25% NH4OH solution, the precipitates were ﬁltered
off, and the supernatants were evaporated, giving rise to 5,6-O-iso-
propylidene galactofuranosides, named GFA-Me-IP and GFB-Me-IP.2.2. Spectrometric and spectroscopic analyses of the
galactofuranosides
The identiﬁcation and quantiﬁcation of the derivatives was per-
formed by GC–MS on the glycoside acetate form of the derivatives
[7]. Pure glycosides (10 lg mL1) were also analysed by soft ionisa-
tion; these were solubilised in MeOH–H2O (7:3, v/v) containing
5 mM LiCl and submitted to positive API-ESI-MS using a Quattro
LC triple quadrupole mass spectrometer (Waters). NMR measure-
ments were performed after deuterium exchange in a Bruker
400 MHz AVANCE III NMR spectrometer with a 5 mm inverse gra-
dient probe. Spectra were obtained from solutions in CDCl3,
CDCl3:CD3OD (2:1, v/v) or D2O at 30 C using TSP as an internal
standard (d = 0). Observation and conversion of GFB-Me-IP to
GFB-Me was performed in D2O in acetate buffer, pH 5.0, at 40 C
from 12 to 120 h. All the 1H and 13C assignments were obtained
by 1D and 2D NMR experiments using COSY, HSQC, HSQC-TOCSY
and HMBC pulse sequences.2.3. In vitro biological experiments
2.3.1. Animals
Male albino Swiss mice (3 months old, weighing 25–30 g) from
the Universidade Federal do Paraná were used for biological tests.
They were maintained under standard laboratory conditions with a
constant 12 h light/dark cycle and controlled temperature
(22 ± 2 C); standard pellet food (Nuvital, Curitiba/PR, Brazil)
and water were available ad libitum. All experimental procedures
were performed in strict accordance with the recommendations
in the Guide for the Care and Use of Laboratory Animals of the Na-
tional Institutes of Health and were previously approved by the
Institutional Ethics Committee of the university (authorisation
number 430).
2.3.2. Macrophage isolation
Resident macrophages were obtained by intraperitoneal (i.p.)
washing of the mouse peritoneal cavity with 10 mL sterile phos-
phate buffered saline (PBS). Peritoneal cells were collected by
centrifugation (290 g, 4 C for 5 min), washed, resuspended in
PBS or RPMI medium and counted in a Neubauer chamber by
optical microscopy using a Trypan blue solution (1%). Peritoneal
cells were characterised by ﬂow cytometry, conﬁrming their via-
bility by side scattering. Macrophages were further puriﬁed by
incubating peritoneal cells in tissue culture plates for 2 h and
then washing three times with PBS to remove the non-adherent
cells.
2.3.3. Phagocytic capacity, H2O2, O

2 , and NO production
Colorimetric assays were carried out to measure the effects of
the galactofuranosides on some properties of macrophages. The
phagocytic assay was performed as described by Bonatto et al.
[8]. Aliquots (0.1 mL) of macrophage suspension were added to
the wells of a 96-well X ﬂat-bottomed tissue culture plate. Neutral
red-stained non-opsonized zymosan (0.01 mL, 1.0  108 parti-
cles mL1) was then added to each well, the solution was incubated
with the synthetic galactofuranosides and commercial methyl-b-D-
galactopyranoside (Sigma–Aldrich, MO, USA) for 2 h at 37 C, and
absorbance values were obtained at 550 nm. Hydrogen peroxide
production by peritoneal macrophages was determined as de-
scribed by Pick and Mizel [9]. Macrophages (ﬁnal volume 0.1 mL)
were incubated in the presence of glucose (5 mM), phenol red solu-
tion (0.56 mM), and HRPO (8.5 U ml1), and absorbance was mea-
sured at 620 nm [9]. Superoxide production was estimated using a
nitroblue tetrazolium (NBT) reduction assay, and the formation of
blue formazan was quantiﬁed at 560 nm [10]. Nitric oxide was
measured as nitrite (NO2 ). The nitrite concentration was measured
by the Greiss reaction, and the absorbance was measured at
550 nm NO2 [11]. In all assays that evaluated reactive oxygen spe-
cies production, the same conditions were followed: macrophages
(105 cells in ﬁnal volume of 0.1 mL) were incubated for 24 h in the
presence of macrophage activating substances LPS (0.1 lg mL1) or
PMA (1 lg mL1).
2.4. In vivo test
2.4.1. Mouse model of polymicrobial sepsis
Polymicrobial sepsis was induced by cecal ligation and punc-
ture (CLP) in mice, as previously described [12,13]. Brieﬂy, mice
were anesthetised by intraperitoneal injection of ketamine
(80 mg kg1) and xylazine (20 mg kg1), and a small abdominal
midline incision was made. The cecum was then isolated, ligated
with a silk ligature just distal to the ileocecal valve, and punctured
six times at the opposite ends with a 22-gauge needle. A small
amount of cecal contents was expressed through the puncture
wound, and the cecum was returned to the abdominal cavity. Fol-
Fig. 1. 13C NMR spectra of galactofuranoside derivatives. (A) GFB-Me, (B) GFB-Me-IP, (C) GFB-O, (D) GFA-Me, (E) GFA-Me-IP, (F) GFA-O. All NMR spectra were obtained at
30 C in D2O (A and D), CDCl3 (B and E) and CDCl3:MeOD (C and F). Chemical shifts are expressed in PPM. (G) Synthetic galactofuranoside derivatives: (I) GFB-Me, (II) GFA-Me,
(III) GFB-Me-IP, (IV) GFA-Me-IP, (V) GFB-O, (VI) GFA-O.
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1 mL sterile saline was subcutaneously administered for ﬂuid
resuscitation. After surgery, the mice were placed on a heating
pad until they recovered from the anaesthesia. The mice were gi-
ven food and water ad libitum throughout the study. Survival was
monitored for 7 days (n = 8 animals in each group).2.4.2. Experimental protocols
Mice were randomly assigned to ﬁve groups: (a) Sham or False-
operated mice, (b) CLP + Saline (positive control), (c) CLP + GFB-Me
(25 mg kg1, test compound), (d) CLP + GFB-Me-IP (25 mg kg1,
test compound) and (e) CLP + antibiotics (Ceftriaxone
100 mg kg1 + Clindamycin 100 mg kg1, negative control). Saline
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after the surgery. The treatments continued during the next few
days, each lasting 12 h.
In the Sham group (or false-operated group), mice were sub-
jected to the same surgical procedure, except that the cecum was
neither ligated nor punctured.2.4.3. Survival test
After CLP surgery, mice were treated and monitored daily (each
12 h) for survival and clinical signs, including mobility, apathy,
conjunctivitis, diarrhoea, dirty nose, and fur rufﬂing for all consec-
utive days.2.5. Ex vivo test
2.5.1. Determination of cytokine levels
The concentrations of tumor necrosis factor alpha (TNF-a),
interleukin (IL)-1b and IL-6 were determined using enzyme-linked
immunosorbent assay (ELISA) kits (R&D Systems, Minneapolis,
MN) according to the manufacturer’s instructions. For the mea-
surement of CLP-induced cytokines, lung samples were collected
6 hours after CLP and saline treatment (NaCl, 0.9%, i.p. positive con-
trol for pro-inﬂammatory cytokines), GFB-Me (25 mg kg1 i.p.),
GFB-Me-IP (25 mg kg1 i.p.), antibiotics (ceftriaxone, 100 mg kg1
plus clindamycin, 100 mg kg1 i.p., negative control) or dexameth-
asone (0.5 mg kg1 i.p., negative control for pro-inﬂammatory
cytokines). A false-operated group (sham) was also provided for
this test.2.5.2. Western blot analysis
The ileum samples were washed twice with PBS and then
homogenised and lysed in extraction buffer (composition in mM:
Tris/HCl, 20 (pH 7.5; QBiogene); NaCl, 150; Na3VO4, sodium pyro-
phosphate, 10; NaF, 20; okadaic acid, 0.01 (Sigma); a tablet of pro-
tease inhibitor (Roche) and 1% Triton X-100 (QBiogen)). Total
proteins (20 lg) were separated on 8% SDS–polyacrylamide (Sig-
ma) gels at 80 V for 2 h. Separated proteins were electrophoreti-
cally transferred onto polyvinylidene diﬂuoride membranes (Bio-
Rad) at 100 V for 120 min. Membranes were blocked with blocking
buffer containing 3% low fat milk powder, Tris-buffered saline
solution (Bio-Rad) and 0.1% Tween 20 (Sigma) (TBS-T) for 1 h.
Membranes were then incubated with primary antibodies for iNOS
(NOS2 Antibody (sc-7271) was provided by Santa Cruz Biotechnol-
ogy, Inc. – USA; 1:1000) overnight at 4 C. After washing, mem-
branes were incubated with the secondary antibody (peroxidase-
labelled anti-mouse IgG, 1:5000) at room temperature for
60 min. The detection of b-tubulin proteins was used for the nor-
malisation and quantiﬁcation of iNOS. Pre-stained markers (Invit-
rogen) were used for molecular mass determinations.
Immunoreactive bands were detected by enhanced chemilumines-
cence (Bio-Rad).2.6. Statistical analysis
Statistical analysis was performed by two-way analysis of vari-
ance using a control and treated as independent factors. Post-hoc
tests were corrected by Tukey’s test for multiple comparisons. Data
were analyzed using Prisma 5.0™ computational software. Values
of p < 0.05 were taken to indicate statistical signiﬁcance.3. Results
3.1. Synthesis and puriﬁcation
Acetylated derivatives of the synthesised glycosides were quan-
tiﬁed by GC–MS [7]. The ratio of Me-b-Galf to Me-a-Galf was 2.3:1
under the conditions described in the Section 2, although small
changes in the reaction temperature gave rise to different ratios,
favoring the a-conﬁguration for a 1:1 ratio. Temperatures higher
than 45 C favored the formation of galactopyranosides, which is
in agreement with previous ﬁndings [14,15].
Puriﬁcation of the methyl, n-octyl and O-isopropylidene galac-
tofuranosides was carried out by column chromatography using
different CHCl3–MeOH solvent mixtures as gradients. Pure methyl
b- and a-galactofuranosides were eluted with CHCl3–MeOH (90:10
v/v) in fractions 25–31 (GFB-Me) and 36–40 (GFA-Me). The n-octyl
derivatives were puriﬁed with CHCl3-2-PrOH (90:10 v/v) by elu-
tion in fractions 16–21 (GFB-O) and 27–33 (GFA-O). The structures
of the Galf derivatives were conﬁrmed by NMR and ESI-MS/MS
analysis (Fig. 1).3.2. Structural analysis of galactofuranosides
NMR assignments of the galactofuranosides were carried out by
1H and 13C NMR spectroscopy (Supplementary Table 1) and were
also compared with assignments found in previous works [14–
18]. In the 13C NMR spectra from the galactofuranosyl derivatives,
typical C-1 signals for a/b conﬁgurations appeared between d
102.5 and 109.3. The structure of the methyl b- and n-octyl b-Galf
derivatives were conﬁrmed by their anomeric chemical shifts at
the low ﬁeld region, d 109.3 and 108.7, respectively (Fig. 1A–C).
Typical signals from methyl and octyl a-D-galactofuranosides ap-
peared at d 102.6 and 102.5 (Fig. 1D, E and F). The resulting chem-
ical shifts from the substituent groups (CH3 and CH2 from the octyl
group) were at d 54.1–56.2 (OCH3) and 71.4–72.8 (O–CH2-octyl);
this was conﬁrmed by NMR DEPT-135. Signals at d 110.4 and 109.6
belonged to the quaternary carbon of the O-isopropylidene ketals,
and their C–(CH3)2 groups were detected at d 27.1–24.8 (Fig. 1B–E).
Signiﬁcant differences between GFB-Me and GFB-Me-IP were ob-
served by 2D-NMR experiments, where these differences were de-
tected along peculiar correlations on COSY and HSQC-TOCSY, as
indicated by the arrows along the 1H/13C correlations (Supplemen-
tary Fig. 1).
The pure fractions were submitted to ESI-MS analysis using the
positive ESI mode as pseudo-molecular ions [M + Li]+ (Supplemen-
tary Fig. 2A–C). GFB-Me and GFA-Me gave rise to identical MS/MS
spectra when obtained at 47 eV with a main ion at m/z 201
[M + Li]+ and minor ones at m/z 169, 127, 111, 93, and 79 (Supple-
mentary Fig. 2A). The octyl b- and a-galactofuranosides also gave
identical fragmentation patterns at the second stage (MS2), with
a pseudo-molecular ion at m/z 299 [M + Li]+ and fragments at m/
z 187, 169, 127, 111, 93, and 79 (Supplementary Fig. 2B). The
5,6-O-isopropylidene GFA-Me or GFB-Me derivatives were ana-
lysed under the same conditions, and as expected, provided the
same pseudo-molecular ions at m/z 241 [M + Li]+. In the MS2 spec-
trum, low abundance fragments at m/z 183, 151, 109, 93, and 79
were formed (Supplementary Fig. 2C).3.3. Phagocytic capacity, H2O2, O

2 , and NO production
Peritoneal macrophages from rats were assayed for phagocytic
activity [8] in the presence of Galf derivatives, b-D-Galp (GPB-Me)
or saline (control); in this experiment, the concentrations were in
lmol mL1. The compounds GFB-O and GFB-Me increased phago-
cytosis, which was 17–52% more frequent than with the control
Fig. 2. In vitro biological activities of the galactofuranosides. Proﬁle of the phagocytic activities of the galactofuranosides. (h) 25 lmol mL1, (j) 50 lmol mL1, (j)
125 lmol mL1, (j) 250 lmol mL1. Data are presented as the mean ± SEM of ﬁve separate experiments relative to the control group. ⁄ Values of p < 0.05 were taken to
indicate statistical signiﬁcance; all the galactofuranoside derivatives gave rise to statistically signiﬁcant phagocytic activities.
Fig. 3. (A) Production of nitric oxide (NO) by peritoneal macrophages with different
concentrations of galactofuranosides: (h) 25 lmol mL1, (j) 125 lmol mL1, (j)
250 lmol mL1. Adherent macrophages were incubated for 24 h; C (medium), LPS
(0.1 lg mL1) was used as a positive control for NO production. NO accumulation
was measured in the supernatant using the Griess reaction and calculated as lmol
nitrite/nitrate. (B) Production of hydrogen peroxide by peritoneal macrophages
with different concentrations of galactofuranosides: (h) 25 lmol mL1, (j)
125 lmol mL1, (j) 250 lmol mL1; C, culture media. (C) Production of superoxide
anion by peritoneal macrophages with different concentrations of galactofurano-
sides: (h) 25 lmol mL1, (j) 125 lmol mL1, (j) 250 lmol mL1; PMA (1 lg/mL);
C, culture media. Data are presented as the mean ± SEM of ﬁve separate
experiments relative to the control group. ⁄ Values of p < 0.05 were taken to
indicate statistical signiﬁcance; all the galactofuranoside derivatives gave rise to
statistically signiﬁcant levels of NO or H2O2.
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concentrations.
The octyl and methyl a-galactofuranosides behaved differently,
because while signiﬁcantly less phagocytosis occurred after treat-
ment with these compounds when compared with the control
(Fig. 2), a greater reduction was observed for the 5,6-O-isopropyl-
idene derivatives GFA-Me and GFB-Me, varying from 5% to 56%
when compared to the control. The GPB-Me had a similar behavior
to the saline solution (control), as observed previously by Suzuki
et al. [19], who used p-nitrophenyl-b-D-galactopyranoside to eval-
uate Leishmania infectivity in macrophages by their phagocytic
index.
To evaluate the role of the galactofuranosides in macrophage
functions, these compounds were tested for NO production at con-
centrations of 25, 50, 125, and 250 lmol mL1. All the galactofur-
anosides except for GFA-Me-IP stimulated the NO pathway with
the lowest dose, although responses were not dose-dependent,
suggesting a saturation of NO production at the highest concentra-
tions (Fig. 3A).
Macrophage activation was also observed via H2O2 production
after exposure of the cells to the galactofuranosides for 2 h. The
stimulus was dose-dependent for all derivatives and was more sig-
niﬁcant with GFB-Me-IP, which varied from 1.2- to 3-fold from the
lowest to the highest concentration tested (250 lmol ml1;
Fig. 3B). Considering that O2 molecules can be converted to H2O2
by superoxide dismutase enzymes (SOD) contained in the cells,
this could explain why O2 production gave a lower response
(Fig. 3C).
3.4. Effects of galactofuranosides GFB-Me and GFB-Me-IP on the
survival rate of septic mice
Since GFB-Me and GFB-Me-IP demonstrated the most signiﬁ-
cant effects of phagocytic activity on isolated macrophages, they
were selected for in vivo tests in cases of murine sepsis. Sepsis is
a considerable health problem and a leading cause of death in
many intensive care units [20–22].
The results of the survival experiments are shown in Fig. 4. Mice
treated with saline started to die 48 h after CLP, with a death rate
reaching 57.2% and 27.6% at 60 and 96 h post-CLP, respectively.
The overall mortality at the end of the observation period was
100%, and the area under the curve was 7.605 (arbitrary units).
The lethality was markedly increased in mice subcutaneously trea-
Fig. 4. Effects of the galactofuranosides, GFB-Me and GFB-Me-IP, on the rate of
survival for septic mice. Mice were randomly divided into ﬁve groups. All groups
except the sham group received cecal ligation and puncture (CLP) surgery. Vehicle
and drugs were administered twice at 1 h and 3 h after CLP. The treatments
continued during the following days, each treatment lasting 12 h. The survival rate
of mice was recorded every 12 h for 168 h after CLP. N = 8. ⁄p < 0.05 when compared
to control (Saline group).
Fig. 5. Effect of the galactofuranosides, GFB-Me and GFB-Me-IP, saline and
dexamethasone upon TNF-a (A), IL-1b (B) and IL-6 (C) production in the lungs of
septic mice. Mice received sterile saline (NaCl, 0.9%, i.p., C), GFB-Me (25 mg kg1 -
i.p.), GFB-Me-IP (25 mg kg1 i.p.) or dexametasone (Dexa, 0.5 mg kg1 i.p.) during
the CLP surgery, and the levels of cytokines were evaluated 6 h after the onset. Each
group represents the mean of four to ﬁve animals, and the vertical bars, the SEM.
⁄p < 0.05 compared with sham group; #p < 0.05, ##p < 0.01, compared with the
control group (C); op < 0.05, oop < 0.01, ooop < 0.001 compared with GFB-Me. ANOVA
was followed by Bonferroni’s test.
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was decreased to 3.750 and 4.500, respectively, after treatment
with 25 mg kg1 of the compounds. At the end of the study, the
overall lethality (100%) in both groups was reached at the time
of 120 h. Antibiotic treatment induced an increase in the survival
rate (area under the curve: 12.291). No death was observed in
the sham-operated mice, and the area under the corresponding
lethality curve was 16.800 (arbitrary units).
3.5. Galactofuranoside derivative pre-treatment increases CLP-induced
cytokine release in lungs
TNF-a, IL-1b and IL-6 cytokine levels were low in sham surgery
control mice. In contrast, 6 h after CLP surgery, these cytokines
showed an increase of 49.2%, 74.8% and 70.5%, respectively, in mice
that underwent the surgery in comparison to the sham group.
Treatment with GFB-Me-IP resulted in a signiﬁcant increase in
cytokine production in relation to the saline group. GFB-Me-IP
(25 mg kg1) increased the levels of TNF-a, IL-1b and IL-6 by
35.5%, 48.2% and 46.8%, respectively. The levels of these cytokines
were minimally changed by GFB-Me-IP treatment in the estimated
time. The increase in the levels of TNF-a, IL-1b and IL-6 was signif-
icantly prevented by the addition of 0.5 mg kg1 dexamethasone
(33.4%, 73.7% and 65% inhibition, respectively, in comparison to
the control group (Fig. 5A–C).
3.6. Interference of pH on GFB-Me-IP to GFB-Me conversion
The conversion of GFB-Me-IP to GFB-Me was measured by 1H
NMR spectroscopy at similar conditions of pH and temperature
to those observed in inﬂamed tissues. The formation of aceton
and changes in the anomeric protons showed that the conversion
reached 45% after 48 h (Fig. 6). Therefore, this in vivo molecular
change contributes to the resulting similar effects of GFB-Me-IP
and GFB-Me on septic mouse mortality, although GFB-Me-IP
showed lethal effects 12 h after GFB-Me.
3.7. GFB-Me-IP induces the expression of iNOS in ileum
Since treatment with GFB-Me and GFB-Me-IP had signiﬁcant
pro-inﬂammatory effects (increase in mortality, phagocytic activ-
ity and the production of pro-inﬂammatory cytokines and reactive
oxygen species), we investigated the tissue expression of a pro-
inﬂammatory enzyme (inducible Nitric Oxide Synthase – iNOS)
in ileum that is closely linked to sepsis and high NO production.
The iNOS level was assessed by immunoblotting 6 h after the treat-
ments. GFB-Me (25 mg kg1) increased the expression of iNOS by
28, 33% in comparison to the control group. At the evaluated time(6 h), the iNOS expression was unchanged by GFB-Me-IP treat-
ment. Dexamethasone signiﬁcantly affected iNOS expression with
a reduction of 45.7% (Fig. 7A and B).4. Discussion
The external layers of living organisms contain glycoconjugates
that are involved in many functions related to the speciﬁc recogni-
tion of events in the extracellular environment and the induction
of the immune system [21,23]. It has been well documented that
the basic mechanism of the immunomodulation, anti-tumor, bac-
tericidal and other therapeutic effects of carbohydrate-containing
molecules occurs via macrophage stimulation [23–26]. Conse-
quently, the modulation of innate immunity has a signiﬁcant im-
Fig. 6. 1H NMR spectra of GFB-Me-IP over 120 h, showing its conversion to GFB-Me at 40 C in buffered D2O at pH 5.0. Sections from 1H NMR spectra: anomeric region (H1-
GFB-Me, 4.903 ppm and H1-GFB-Me-IP, 4.928 ppm); O-Me glycoside (Me-GFB-Me, 3.411 ppm and Me-GFB-Me-IP, 3.417 ppm); aceton (Me at 2.224 ppm); 5,6-O-
isopropylidene (Me at 1.476 and 1.408).
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verse array of pathogens [26].
Thus, we have focused this work on the role of galactofuranosyl
epitopes, which have been observed in pathogenic microorgan-
isms, on the phagocytic capacity of macrophages and its implica-
tion on mortality that is induced by sepsis.
The strategies adopted to evaluate phagocytic activity showed
some important structural features that are necessary for the rec-
ognition of galactofuranose-containing molecules. The anomeric
conﬁguration is a determinant of phagocytic activity, because the
b-anomers have much more activity than the a-anomers. Both
derivatives, GFB-Me and GFB-O, were immune-stimulatory be-
cause they enhanced phagocytic activity by 48% relative to the
physiological control. It was also found that in the high concentra-
tion tested here, there was little activity; this behavior corresponds
well to receptor saturation on the macrophage membranes [27].
Interestingly, the GFA-Me and GFA-O derivatives had immune sup-
pressor effects of 15%. These results clearly show that the b-
conﬁguration is essential for phagocytic activity. In addition, the
aglycone substituent interferes with phagocytic activity because
it had to be increased at least 2-fold to reach the same level of
stimulation; however, some differences might be observedin vivo, because alkyl groups increase the lipophilicity of the mol-
ecules, and this is essential for drug absorption.
The selective blocking of HO-5,6 groups in GFB-Me and GFA-Me
demonstrated a highly negative immune effect. GFB-Me-IP had a
negative effect of about 47%, and this shows the direct inﬂuence
of the glycosidic conﬁguration, as well as the importance of the
free hydroxyls at C-5 and C-6 on the furanosidic ring. These obser-
vations suggest that the free HO-5 and HO-6 groups and the b-con-
ﬁguration are essential structures for the galactofuranosyl unit in
macrophage phagocytic activation. GPB-Me has no effect on the
phagocytic activity, suggesting that the ring conformation is essen-
tial to the biological activity; this was also conﬁrmed by the ab-
sence of NO production. These results reveal new perspectives on
and conﬁrm some previous observations regarding glycan function
and the immunomodulatory responses of glycoconjugates [1–
5,28–30].
Moreover, GFB-Me and GFB-Me-IP showed a signiﬁcant de-
crease in the survival rate of septic mice, and both substances were
used in subsequent in vivo tests. The surgery where peritonitis is
induced by cecal ligation and puncture (CLP) demonstrates clinical
features of polymicrobial infection that are comparable to those of
peritonitis in humans. Septic peritonitis is characterised by bacte-
Fig. 7. GFB-Me induces iNOS expression in the ileums of infected mice. Mice were
treated with GFB-Me, GFB-Me-IP (both 25 mg kg1, s.c.) or dexamethasone
(0.5 mg kg1, s.c.). The levels of iNOS were determined by western blot analysis.
Detection of b-tubulin was used for normalization. A Representative immunoblots.
Results are shown as the means ± SEM of 2–3 different experiments. ⁄⁄⁄p < 0.001,
versus sham. ###p < 0.001, versus vehicle control.
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phils and macrophages into the peritoneum [31]. Bacterial factors
in the bloodstream induce the overexpression of various inﬂamma-
tory mediators, such as interleukin-1b (IL-1b), tumor necrosis fac-
tor-a (TNF-a), interleukin-6 (IL-6), nitric oxide (NO), and
prostanoids, and a large amount of inﬂammatory mediators pro-
duced in the body are thought to contribute to the symptoms of
septic shock and mortality [31–35]. The results clearly demon-
strate that GFB-Me and GFB-Me-IP both signiﬁcantly increase the
mortality rate of septic mice, which reinforces that galactofurano-
syl epitopes are components of pathogens [36]. However, GFB-Me
demonstrated lethal effects more quickly than did GFB-Me-IP.
These data contradict our previous results obtained on macro-
phage phagocytic activity, in which GFB-Me and GFB-Me-IP caused
opposite effects on phagocytic activity: activation and inhibition,
respectively. The underlying cause for this discrepancy may be
partly attributed to the chemical properties of GFB-Me-IP. The
pH levels in inﬂamed tissues decrease to 5.4 [37–39], and exposure
to this acidic environment and corporal temperature might con-
tribute over time to the spontaneous loss of the GFB-Me-IP acetal
group, generating its precursor, GFB-Me, which is immunostimula-
tory. Isopropylidene groups have been easily removed under mild
acidic conditions [40]. Therefore, this molecular change contrib-
utes to the resulting similar effects of GFB-Me-IP and GFB-Me on
septic mouse mortality, although GFB-Me-IP becomes lethal 12 h
after GFB-Me does. In our opinion, this delay occurs because of
the time that is necessary for the reaction to yield signiﬁcant
amounts of GFB-Me to achieve the lethal concentration. There
are many compounds whose availability changes in altered acid-
base states [41–43]. In order to prove this behavior, we measure
the conversion of GFB-Me-IP to GFB-Me by 1H NMR spectroscopy
at conditions of pH and temperature that are similar to those ob-
served in inﬂamed tissues. The formation of aceton and changes
in the anomeric protons showed that the conversion reached 45%
after 48 h (Fig. 6), proving the weak nature of acetal bonds under
mild acidic conditions and ﬁtting well with the data on the survival
rate of septic mice (Fig. 4).
Several studies have demonstrated that TNF-a, IL-1b and IL-6
production, as well as NO production by the inducible isoform of
nitric oxide synthase (iNOS), are among the stronger factors asso-ciated with sepsis syndrome [43–46]. The stimulation of cytokine
overproduction and NO release during early sepsis may worsen
the outcome of sepsis [47–49]. In our results, TNF-a, IL-1b and
IL-6 levels, as well as iNOS expression, dramatically increased in
lung and ileum homogenates by 6 h after CLP surgery. Treatment
with GFB-Me stimulated an increase in all evaluated parameters,
while GFB-Me-IP did not modify them in the evaluated time. As
we have already mentioned, GFB-Me-IP demonstrated lethal ef-
fects later than did GFB-Me, and we have conﬁrmed that GFB-
Me-IP needs at least 48 h for 45% of it to be converted to GFB-
Me, which exacerbates the effects of sepsis. In the chosen time
(6 h), we showed that this process had not ﬁnished (Fig. 6), and
the cytokine levels and iNOS expression after GFB-Me-IP treatment
are similar to the control group at this time, but are signiﬁcantly
lower than those of the GFB-Me group. Additionally, the positive
control (dexamethasone) inhibited the pro-inﬂammatory cyto-
kines and iNOS expression, aiding in the experimental validation
(Fig. 5 and 7).
5. Conclusions
The structural features of synthesised Galf showed the impor-
tance of free HO-5 and HO-6 and a b-conﬁguration for phagocytic
activity. Moreover, the sepsis model was essential for observing
the hyper-activation of the system via the production of a large
quantity of pro-inﬂammatory mediators. These ﬁndings also can
facilitate the discovery of new targets for therapeutic applications
as pro-stimulating agents and novel drugs against pathogenic fun-
gi, protozoa and other pathogenic organisms.
Acknowledgements
The authors wish to thank the Brazilian agencies Fundação
Araucária, Financiadora de Estudos e Projetos (FINEP), Coordenação
de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Progra-
ma de apoio a núcleos de Excelência (PRONEX-Carboidratos) and
the Conselho Nacional de Desenvolvimento Cientíﬁco e Tecnológi-
co (CNPq) for ﬁnancial support.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.cbi.2013.05.014.
References
[1] M.R. Pinto, E. Barreto-Bergter, C.P. Taborda, Glycoconjugates and
polysaccharides of fungal cell wall and activation of immune system, Braz. J.
Microbiol. 39 (2) (2008) 195–208.
[2] E. Suzuki, A.K. Tanaka, M.S. Toledo, S.B. Levery, A.H. Straus, H.K. Takahashi,
Trypanosomatid and fungal glycolipids and sphingolipids as infectivity factors
and potential targets for development of new therapeutic strategies, Biochim.
Biophys. Acta 1780 (3) (2008) 362–369.
[3] L.L. Pedersen, S.J. Turco, Galactofuranose metabolism: a potential target for
antimicrobial chemotherapy, Cell. Mol. Life Sci. 60 (2) (2003) 259–266.
[4] M.V. De Arruda, W. Colli, B. Zingales, Terminal beta-D-galactofuranosyl
epitopes recognized by antibodies that inhibit Trypanosoma cruzi
internalization into mammalian cells, Eur. J. Biochem. 182 (2) (1989) 413–421.
[5] G.L. Sassaki, P.A. Czelusniak, V.A. Vicente, S.M. Zanata, L.M. Souza, P.A. Gorin,
M. Iacomini, Some biomolecules and a partially O-acetylated exo-
galactomannan containing b-Galf units from pathogenic Exophiala jeanselmei,
having a pronounced immunogenic response, Int. J. Biol. Macromol. 48 (1)
(2011) 177–182.
[6] S. Tsuji, J. Uehori, M. Matsumoto, Y. Suzuki, A. Matsuhisa, K. Toyoshima, T.
Seya, Human intelectin is a novel soluble lectin that recognizes
galactofuranose in carbohydrate chains of bacterial cell wall, J. Biol. Chem.
276 (26) (2001) 23456–23463.
[7] G.L. Sassaki, L.M. Souza, R.V. Serrato, T.R. Cipriani, P.A. Gorin, M. Iacomini,
Application of acetate derivatives for gas chromatography–mass
spectrometry: novel approaches on carbohydrates, lipids and amino acids
analysis, J. Chromatogr. A 1208 (1–2) (2008) 215–222.
G.L. Sassaki et al. / Chemico-Biological Interactions 205 (2013) 29–37 37[8] S.J. Bonatto, A. Folador, J. Aikawa, R.K. Yamazaki, N. Pizatto, H.H. Oliveira, R.
Vecchi, R. Curi, P.C. Calder, L.C. Fernandes, Lifelong exposure to dietary ﬁsh oil
alters macrophage responses in Walker 256 tumor-bearing rats, Cell. Immunol.
231 (1–2) (2004) 56–62.
[9] E. Pick, D. Mizel, Rapid microassays for the measurement of superoxide and
hydrogen peroxide production by macrophages in culture using an automatic
enzyme immunoassay reader, J. Immunol. Methods 46 (2) (1981) 211–226.
[10] N. Madhavi, U.N. Das, Effect of n-6 and n-3 fatty acids on the survival of
vincristine sensitive and resistant human cervical carcinoma cells in vitro,
Cancer Lett. 84 (1) (1994) 31–41.
[11] D.J. Stuehr, M.A. Marletta, Mammalian nitrate biosynthesis: mouse
macrophages produce nitrite and nitrate in response to Escherichia coli
lipopolysaccharide, Proc. Natl. Acad. Sci. USA 82 (22) (1985) 7738–7742.
[12] M.P. Fink, S.O. Heard, Laboratory models of sepsis and septic shock, J. Surg. Res.
49 (2) (1990) 186–196.
[13] M.S. Kim, G.S. Bae, K.C. Park, B.S. Koo, B.J. Kim, H.J. Lee, S.W. Seo, Y.K. Shin, W.S.
Jung, J.H. Cho, Y.C. Kim, T.H. Kim, H.J. Song, S.J. Park, Myrrh inhibits LPS-
induced inﬂammatory response and protects from cecal ligation and
puncture-induced sepsis, Evid. Based Complement. Alternat Med. 2012
(2012) 278718.
[14] G.L. Sassaki, M. Iacomini, P.A.J. Gorin, Methylation-GC-MS analysis of
arabinofuranose- and galactofuranose-containing structures: rapid synthesis
of partially O-methylated alditol acetate standards, An. Acad. Bras. Cienc. 77
(2) (2005) 223–234.
[15] G.L. Sassaki, P.A. Gorin, L.M. Souza, P.A. Czelusniak, M. Iacomini, Rapid
synthesis of partially O-methylated alditol acetate standards for GC–MS: some
relative activities of hydroxyl groups of methyl glycopyranosides on Purdie
methylation, Carbohydr. Res. 340 (4) (2005) 731–739.
[16] C. Marino, O. Varela, R.M. de Lederkremer, Synthesis of galactofuranose
disaccharides of biological signiﬁcance, Carbohydr. Res. 190 (1) (1989) 65–76.
[17] V. Ferrières, M. Gelin, R. Boulch, L.c. Toupet, D. Plusquellec, An efﬁcient route to
per-O-acetylated hexofuranoses, Carbohydr. Res. 314 (1–2) (1998) 79–83.
[18] G.C. Completo, T.L. Lowary, Synthesis of galactofuranose-containing acceptor
substrates for mycobacterial galactofuranosyltransferases, J. Org. Chem. 73
(12) (2008) 4513–4525.
[19] E. Suzuki, A.K. Tanaka, M.S. Toledo, H.K. Takahashi, A.H. Straus, Role of beta-D-
galactofuranose in Leishmania major macrophage invasion, Infect. Immun. 70
(12) (2002) 6592–6596.
[20] C.F. Fortin, P.P. McDonald, T. Fülöp, O. Lesur, Sepsis, leukocytes, and nitric
oxide (NO): an intricate affair, Shock 33 (4) (2010) 344–352.
[21] A.O. Tzianabos, Polysaccharide immunomodulators as therapeutic agents:
structural aspects and biologic function, Clin. Microbiol. Rev. 13 (4) (2000)
523–533.
[22] R.C. Bone, Sir Isaac Newton, sepsis, SIRS, and CARS, Crit. Care Med. 24 (7)
(1996) 1125–1128.
[23] I.A. Schepetkin, M.T. Quinn, Botanical polysaccharides: macrophage
immunomodulation and therapeutic potential, Int. Immunopharmacol. 6 (3)
(2006) 317–333.
[24] G. Chihara, Recent progress in immunopharmacology and therapeutic effects
of polysaccharides, Dev. Biol. Stand. 77 (1992) 191–197.
[25] S.Y. Wang, M.L. Hsu, H.C. Hsu, C.H. Tzeng, S.S. Lee, M.S. Shiao, C.K. Ho, The anti-
tumor effect of Ganoderma lucidum is mediated by cytokines released from
activatedmacrophages and T lymphocytes, Int. J. Cancer 70 (6) (1997) 699–705.
[26] B. Beutler, Innate immunity: an overview, Mol. Immunol. 40 (12) (2004) 845–
859.
[27] B. Mantovani, M. Rabinovitch, V. Nussenzweig, Phagocytosis of immune
complexes by macrophages. Different roles of the macrophage receptor sites
for complement (C3) and for immunoglobulin (IgG), J. Exp. Med. 135 (4)
(1972) 780–792.
[28] C.G. Mellinger, E.R. Carbonero, G.R. Noleto, T.R. Cipriani, M.B. Oliveira, P.A.
Gorin, M. Iacomini, Chemical and biological properties of an arabinogalactan
from Phyllanthus niruri, J. Nat. Prod. 68 (10) (2005) 1479–1483.[29] V.C. Bittencourt, R.T. Figueiredo, R.B. da Silva, D.S. Mourão-Sá, P.L. Fernandez,
G.L. Sassaki, B. Mulloy, M.T. Bozza, E. Barreto-Bergter, An alpha-glucan of
Pseudallescheria boydii is involved in fungal phagocytosis and Toll-like
receptor activation, J. Biol. Chem. 281 (32) (2006) 22614–22623.
[30] L.M. Cordeiro, S.M. de Oliveira, D.F. Buchi, M. Iacomini, Galactofuranose-rich
heteropolysaccharide from Trebouxia sp., photobiont of the lichen Ramalina
gracilis and its effect on macrophage activation, Int. J. Biol. Macromol. 42 (5)
(2008) 436–440.
[31] J.A. Russel, The current management of septic shock, Minerva Med. 99 (5)
(2008) 431–458.
[32] J. Cohen, The immunopathogenesis of sepsis, Nature 420 (6917) (2002) 885–
891.
[33] R.S. Hotchkiss, I.E. Karl, The pathophysiology and treatment of sepsis, N. Engl. J.
Med. 348 (2) (2003) 138–150.
[34] S. Gordon, The macrophage: past, present and future, Eur. J. Immunol. 37
(Suppl. 1) (2007) S9–S17.
[35] F.O. Martinez, A. Sica, A. Mantovani, M. Locati, Macrophage activation and
polarization, Front. Biosci. 13 (2008) 453–461.
[36] T. Hartung, A. Sauer, C. Hermann, F. Brockhaus, A. Wendel, Overactivation of
the immune system by translocated bacteria and bacterial products, Scand. J.
Gastroenterol. Suppl. 222 (1997) 98–99.
[37] K.H. Steen, P.W. Reeh, F. Anton, H.O. Handwerker, Protons selectively induce
lasting excitation and sensitization to mechanical stimulation of nociceptors in
rat skin, in vitro, J. Neurosci. 12 (1) (1992) 86–95.
[38] Y. Kajihara, M. Murakami, T. Imagawa, K. Otsuguro, S. Ito, T. Ohta, Histamine
potentiates acid-induced responses mediating transient receptor potential V1
in mouse primary sensory neurons, Neuroscience 166 (1) (2010) 292–304.
[39] P. Holzer, Acid sensing by visceral afferent neurones, Acta Physiol. (Oxf) 201
(1) (2011) 63–75.
[40] W.L. Wu, Y.L. Wu, J. Org. Chem. 58 (13) (1993) 3586–3588.
[41] H. Hilmarsson, T. Kristmundsdóttir, H. Thormar, Virucidal activities of
medium- and long-chain fatty alcohols, fatty acids and monoglycerides
against herpes simplex virus types 1 and 2: comparison at different pH
levels, APMIS 113 (1) (2005) 58–65.
[42] M. Shiino, Y. Watanabe, K. Umezawa, PH-dependent inhibition of mushroom
tyrosinase by N-substituted N-nitrosohydroxylamines, J. Enzyme Inhib. Med.
Chem. 23 (1) (2008) 16–20.
[43] J. Ramadoss, G. Wu, T.A. Cudd, Chronic binge ethanol-mediated acidemia
reduces availability of glutamine and related amino acids in maternal plasma
of pregnant sheep, Alcohol 42 (8) (2008) 657–666.
[44] A. Takala, I. Nupponen, M.L. Kylänpää-Bäck, H. Repo, Markers of inﬂammation
in sepsis, Ann. Med. 34 (7–8) (2002) 614–623.
[45] D. Mokart, M. Merlin, A. Sannini, J.P. Brun, J.R. Delpero, G. Houvenaeghel, V.
Moutardier, J.L. Blache, Procalcitonin, interleukin 6 and systemic inﬂammatory
response syndrome (SIRS): early markers of postoperative sepsis after major
surgery, Br. J. Anaesth. 94 (6) (2005) 767–773.
[46] D.A. Bonville, T.S. Parker, D.M. Levine, B.R. Gordon, L.J. Hydo, S.R. Eachempati,
P.S. Barie, The relationships of hypocholesterolemia to cytokine concentrations
and mortality in critically ill patients with systemic inﬂammatory response
syndrome, Surg. Infect. (Larchmt) 5 (1) (2004) 39–49.
[47] M.F. Osuchowski, K. Welch, J. Siddiqui, D.G. Remick, Circulating cytokine/
inhibitor proﬁles reshape the understanding of the SIRS/CARS continuum in
sepsis and predict mortality, J. Immunol. 177 (3) (2006) 1967–1974.
[48] S. Ebong, D. Call, J. Nemzek, G. Bolgos, D. Newcomb, D. Remick,
Immunopathologic alterations in murine models of sepsis of increasing
severity, Infect. Immun. 67 (12) (1999) 6603–6610.
[49] T. Brenner, J. Motsch, J. Werner, L. Grenacher, E. Martin, S. Hofer, Rapid-onset
acute respiratory distress syndrome (ARDS) in a patient undergoing metastatic
liver resection: a case report and review of the literature, Anesthesiol. Res.
Pract. (2010). http://dx.doi.org/10.1155/2010/586425.
